{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:19:27Z","timestamp":1792556367418,"version":"4.5.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1177\/1933719116638186","type":"journal-article","created":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T00:24:13Z","timestamp":1459556653000},"page":"1314-1325","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Identification of Polycomb Group Protein EZH2-Mediated DNA Mismatch Repair Gene MSH2 in Human Uterine Fibroids"],"prefix":"10.1007","volume":"23","author":[{"given":"Qiwei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Laknaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lelyand","family":"Elam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahed","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Gavrilova-Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Al-Hendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,1]]},"reference":[{"issue":"14","key":"23101314_CR1","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","volume":"369","author":"SE Bulun","year":"2013","unstructured":"Bulun, SE Uterine fibroids. N Engl J Med. 2013;369(14): 1344\u20131355.","journal-title":"N Engl J Med"},{"issue":"4","key":"23101314_CR2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/humupd\/dml015","volume":"12","author":"A Al-Hendy","year":"2006","unstructured":"Al-Hendy, A, Salama, S Gene therapy and uterine leiomyoma: a review. Hum Reprod Update. 2006;12(4):385\u2013400.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"23101314_CR3","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.fertnstert.2014.06.040","volume":"102","author":"HR Heinonen","year":"2014","unstructured":"Heinonen, HR, Sarvilinna, NS, Sjoberg, J, et al. MED12 mutation frequency in unselected sporadic uterine leiomyomas. Fertil Steril. 2014;102(4):1137\u20131142.","journal-title":"Fertil Steril"},{"issue":"4","key":"23101314_CR4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/PAT.0b013e328360bf97","volume":"45","author":"RJ Rieker","year":"2013","unstructured":"Rieker, RJ, Agaimy, A, Moskalev, EA, et al. Mutation status of the mediator complex subunit 12 (MED12) in uterine leiomyomas and concurrent\/metachronous multifocal peritoneal smooth muscle nodules (leiomyomatosis peritonealis disseminata). Pathology. 2013;45(4):388\u2013392.","journal-title":"Pathology"},{"issue":"2","key":"23101314_CR5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00438-014-0938-x","volume":"290","author":"SK Halder","year":"2015","unstructured":"Halder, SK, Laknaur, A, Miller, J, Layman, LC, Diamond, M, Al- Hendy, A Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids. Mol Genet Genomics. 2015;290(2):505\u2013511.","journal-title":"Mol Genet Genomics"},{"issue":"8","key":"23101314_CR6","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/modpathol.2013.243","volume":"27","author":"E Bertsch","year":"2014","unstructured":"Bertsch, E, Qiang, W, Zhang, Q, et al. MED12 and HMGA2 muta-tions: two independent genetic events in uterine leiomyoma and leiomyosarcoma. Mod Pathol. 2014;27(8):1144\u20131153.","journal-title":"Mod Pathol"},{"issue":"13","key":"23101314_CR7","first-page":"3766","volume":"62","author":"DS Hunter","year":"2002","unstructured":"Hunter, DS, Klotzbucher, M, Kugoh, H, et al. Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function. Cancer Res. 2002;62(13): 3766\u20133772.","journal-title":"Cancer Res"},{"issue":"1-2","key":"23101314_CR8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mrfmmm.2006.07.007","volume":"602","author":"SE Ingraham","year":"2006","unstructured":"Ingraham, SE, Lynch, RA, Surti, U, et al. Identification and char-acterization of novel human transcripts embedded within HMGA2 in t(12;14)(q15;q24.1) uterine leiomyoma. Mutat Res. 2006;602(1-2):43\u201353.","journal-title":"Mutat Res"},{"issue":"6","key":"23101314_CR9","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00404-010-1550-x","volume":"283","author":"GA El-Shennawy","year":"2011","unstructured":"El-Shennawy, GA, Elbialy, AA, Isamil, AE, El Behery, MM Is genetic polymorphism of ER-alpha, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma? Arch Gynecol Obstet. 2011;283(6): 1313\u20131318.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"23101314_CR10","first-page":"200","volume":"47","author":"EM Vikhliaeva","year":"2001","unstructured":"Vikhliaeva, EM Molecular-genetic determinants of the neo-plastic process and state-of-the-art treatment of patients with uterine leiomyoma [in Russian]. Vopr Onkol. 2001;47(2): 200\u2013204.","journal-title":"Vopr Onkol"},{"issue":"1-2","key":"23101314_CR11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11010-009-0347-3","volume":"338","author":"Y Yang","year":"2010","unstructured":"Yang, Y, Zhai, XD, Gao, LB, Li, SL, Wang, Z, Chen, GD Genetic polymorphisms of DNA repair gene XRCC1 and risk of uterine leiomyoma. Mol Cell Biochem. 2010;338(1-2):143\u2013147.","journal-title":"Mol Cell Biochem"},{"issue":"7","key":"23101314_CR12","first-page":"1352","volume":"100","author":"JM Ramos","year":"2004","unstructured":"Ramos, JM, Ruiz, A, Colen, R, Lopez, ID, Grossman, L, Matta, JL DNA repair and breast carcinoma susceptibility in women. Can-cer. 2004;100(7):1352\u20131357.","journal-title":"Can-cer"},{"key":"23101314_CR13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1471-2407-11-278","volume":"11","author":"LJ Ricks-Santi","year":"2011","unstructured":"Ricks-Santi, LJ, Sucheston, LE, Yang, Y, et al. Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk. BMC Cancer. 2011; 11:278.","journal-title":"BMC Cancer"},{"issue":"3","key":"23101314_CR14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc2342","volume":"8","author":"T Helleday","year":"2008","unstructured":"Helleday, T, Petermann, E, Lundin, C, Hodgson, B, Sharma, RA DNA repair pathways as targets for cancer therapy. Nat Rev Can-cer. 2008;8(3):193\u2013204.","journal-title":"Nat Rev Can-cer"},{"issue":"2-3","key":"23101314_CR15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1383-5742(00)00032-6","volume":"462","author":"S Benhamou","year":"2000","unstructured":"Benhamou, S, Sarasin, A Variability in nucleotide excision repair and cancer risk: a review. Mutat Res. 2000;462(2-3): 149\u2013158.","journal-title":"Mutat Res"},{"issue":"3","key":"23101314_CR16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1067\/S0190-9622(03)00918-6","volume":"49","author":"JL Matta","year":"2003","unstructured":"Matta, JL, Villa, JL, Ramos, JM, et al. DNA repair and nonmela-noma skin cancer in Puerto Rican populations. J Am Acad Der-matol. 2003;49(3):433\u2013439.","journal-title":"J Am Acad Der-matol"},{"issue":"10","key":"23101314_CR17","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3109\/10428194.2010.516377","volume":"51","author":"A Belcheva","year":"2010","unstructured":"Belcheva, A, Kolaj, B, Martin, A Missing mismatch repair: a key to T cell immortality. Leuk Lymphoma. 2010;51(10): 1777\u20131778.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"23101314_CR18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrclinonc.2009.237","volume":"7","author":"E Vilar","year":"2010","unstructured":"Vilar, E, Gruber, SB Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev Clin Oncol. 2010;7(3): 153\u2013162.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"23101314_CR19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.2005.01.5180","volume":"24","author":"IM Bachmann","year":"2006","unstructured":"Bachmann, IM, Halvorsen, OJ, Collett, K, et al. EZH2 expression is associated with high proliferation rate and aggressive tumor sub-groups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol. 2006;24(2):268\u2013273.","journal-title":"J Clin Oncol"},{"issue":"20","key":"23101314_CR20","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1073\/pnas.1933744100","volume":"100","author":"CG Kleer","year":"2003","unstructured":"Kleer, CG, Cao, Q, Varambally, S, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A 2003;100(20): 11606\u201311611.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"23101314_CR21","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/ng.3095","volume":"46","author":"W Lee","year":"2014","unstructured":"Lee, W, Teckie, S, Wiesner, T, et al. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nat Genet. 2014;46(11):1227\u20131232.","journal-title":"Nat Genet"},{"issue":"4","key":"23101314_CR22","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1371\/journal.pbio.0060093","volume":"6","author":"IJ Majewski","year":"2008","unstructured":"Majewski, IJ, Blewitt, ME, de Graaf, CA, et al. Polycomb repres-sive complex 2 (PRC2) restricts hematopoietic stem cell activity. PLoS Biol. 2008;6(4):e93.","journal-title":"PLoS Biol"},{"issue":"3","key":"23101314_CR23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/bcr2871","volume":"13","author":"OA Stefansson","year":"2011","unstructured":"Stefansson, OA, Esteller, M EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells. Breast Cancer Res. 2011;13(3):309.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"23101314_CR24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7150\/ijbs.8.59","volume":"8","author":"KH Yoo","year":"2012","unstructured":"Yoo, KH, Hennighausen, L EZH2 methyltransferase and H3K27 methylation in breast cancer. Int J Biol Sci. 2012; 8(1):59\u201365.","journal-title":"Int J Biol Sci"},{"issue":"12","key":"23101314_CR25","doi-asserted-by":"crossref","first-page":"e51239","DOI":"10.1371\/journal.pone.0051239","volume":"7","author":"H Yu","year":"2012","unstructured":"Yu, H, Simons, DL, Segall, I, et al. PRC2\/EED-EZH2 complex is up-regulated in breast cancer lymph node metastasis compared to primary tumor and correlates with tumor proliferation in situ. PloS One. 2012;7(12):e51239.","journal-title":"PloS One"},{"issue":"3","key":"23101314_CR26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4143\/crt.2014.46.3.209","volume":"46","author":"H Yamaguchi","year":"2014","unstructured":"Yamaguchi, H, Hung, MC Regulation and role of EZH2 in cancer. Cancer Res Treat. 2014;46(3):209\u2013222.","journal-title":"Cancer Res Treat"},{"issue":"2","key":"23101314_CR27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/bjc.2011.551","volume":"106","author":"CJ Chang","year":"2012","unstructured":"Chang, CJ, Hung, MC The role of EZH2 in tumour progression. Br J Cancer. 2012;106(2):243\u2013247.","journal-title":"Br J Cancer"},{"issue":"4","key":"23101314_CR28","first-page":"364","volume":"4","author":"YH Chen","year":"2012","unstructured":"Chen, YH, Hung, MC, Li, LY EZH2: a pivotal regulator in con-trolling cell differentiation. Am J Transl Res. 2012;4(4): 364\u2013375.","journal-title":"Am J Transl Res"},{"issue":"5","key":"23101314_CR29","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.molonc.2012.06.002","volume":"6","author":"K Holm","year":"2012","unstructured":"Holm, K, Grabau, D, Lovgren, K, et al. Global H3K27 trimethyla-tion and EZH2 abundance in breast tumor subtypes. Mol Oncol. 2012;6(5):494\u2013506.","journal-title":"Mol Oncol"},{"issue":"2","key":"23101314_CR30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/aps.2013.161","volume":"35","author":"JZ Tan","year":"2014","unstructured":"Tan, JZ, Yan, Y, Wang, XX, Jiang, Y, Xu, HE EZH2: biology, disease, and structure-based drug discovery. Acta Pharmacol Sin. 2014;35(2):161\u2013174.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"23101314_CR31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/jb\/mvu054","volume":"156","author":"Y Kondo","year":"2014","unstructured":"Kondo, Y Targeting histone methyltransferase EZH2 as cancer treatment. J Biochem. 2014;156(5):249\u2013257.","journal-title":"J Biochem"},{"issue":"1","key":"23101314_CR32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ccr.2010.10.035","volume":"19","author":"CJ Chang","year":"2011","unstructured":"Chang, CJ, Yang, JY, Xia, W, et al. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-beta-catenin signaling. Cancer Cell. 2011;19(1):86\u2013100.","journal-title":"Cancer Cell"},{"issue":"4","key":"23101314_CR33","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/bcr2354","volume":"11","author":"J Puppe","year":"2009","unstructured":"Puppe, J, Drost, R, Liu, X, et al. BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to poly-comb repressive complex 2-inhibitor 3-deazaneplanocin. A Breast Cancer Res. 2009;11(4):R63.","journal-title":"A Breast Cancer Res"},{"issue":"11","key":"23101314_CR34","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1593\/neo.05472","volume":"7","author":"M Zeidler","year":"2005","unstructured":"Zeidler, M, Varambally, S, Cao, Q, et al. The polycomb group protein EZH2 impairs DNA repair in breast epithelial cells. Neo-plasia. 2005;7(11):1011\u20131019.","journal-title":"Neo-plasia"},{"issue":"4","key":"23101314_CR35","first-page":"318","volume":"13","author":"BO Akinyemi","year":"2004","unstructured":"Akinyemi, BO, Adewoye, BR, Fakoya, TA Uterine fibroid: a review. Niger J Med. 2004;13(4):318\u2013329.","journal-title":"Niger J Med"},{"issue":"2","key":"23101314_CR36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1933719115584449","volume":"23","author":"Q Yang","year":"2016","unstructured":"Yang, Q, Mas, A, Diamond, MP, Al-Hendy, A The mechanism and function of epigenetics in uterine leiomyoma development. Reprod Sci. 2016;23(2):163\u2013175.","journal-title":"Reprod Sci"},{"issue":"6","key":"23101314_CR37","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.LAB.0000017499.51216.3E","volume":"82","author":"SA Carney","year":"2002","unstructured":"Carney, SA, Tahara, H, Swartz, CD, et al. Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics. Lab Invest. 2002;82(6):719\u2013728.","journal-title":"Lab Invest"},{"issue":"9","key":"23101314_CR38","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/humrep\/det265","volume":"28","author":"SK Halder","year":"2013","unstructured":"Halder, SK, Osteen, KG, Al-Hendy, A Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells. Hum Reprod. 2013;28(9): 2407\u20132416.","journal-title":"Hum Reprod"},{"issue":"9","key":"23101314_CR39","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1093\/humrep\/det275","volume":"28","author":"S Nair","year":"2013","unstructured":"Nair, S, Curiel, DT, Rajaratnam, V, Thota, C, Al-Hendy, A Target-ing adenoviral vectors for enhanced gene therapy of uterine leio-myomas. Hum Reprod. 2013;28(9):2398\u20132406.","journal-title":"Hum Reprod"},{"issue":"2","key":"23101314_CR40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000353426","volume":"76","author":"S Nair","year":"2013","unstructured":"Nair, S, Saed, GM, Atta, HM, et al. Towards gene therapy of post-operative adhesions: fiber and transcriptional modifications enhance adenovirus targeting towards human adhesion cells. Gynecol Obstet Invest. 2013;76(2):119\u2013124.","journal-title":"Gynecol Obstet Invest"},{"key":"23101314_CR41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.vph.2015.04.005","volume":"73","author":"Q Yang","year":"2015","unstructured":"Yang, Q, Sun, M, Ramchandran, R, Raj, JU IGF-1 signaling in neonatal hypoxia-induced pulmonary hypertension: role of epige-netic regulation. Vascular Pharmacol. 2015;73:20\u201331.","journal-title":"Vascular Pharmacol"},{"key":"23101314_CR42","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/1471-2407-10-286","volume":"10","author":"Q Yang","year":"2010","unstructured":"Yang, Q, Tian, Y, Ostler, KR, et al. Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines. BMC Cancer. 2010;10:286.","journal-title":"BMC Cancer"},{"issue":"6","key":"23101314_CR43","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/cpr.12076","volume":"46","author":"Q Yang","year":"2013","unstructured":"Yang, Q, Dahl, MJ, Albertine, KH, Ramchandran, R, Sun, M, Raj, JU Role of histone deacetylases in regulation of phenotype of ovine newborn pulmonary arterial smooth muscle cells. Cell Prolif. 2013;46(6):654\u2013664.","journal-title":"Cell Prolif"},{"issue":"1-2","key":"23101314_CR44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-1119(98)00187-5","volume":"213","author":"Y Iwahashi","year":"1998","unstructured":"Iwahashi, Y, Ito, E, Yanagisawa, Y, et al. Promoter analysis of the human mismatch repair gene hMSH2. Gene. 1998;213(1-2): 141\u2013147.","journal-title":"Gene"},{"issue":"6","key":"23101314_CR45","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00204-015-1474-0","volume":"89","author":"H Yamamoto","year":"2015","unstructured":"Yamamoto, H, Imai, K Microsatellite instability: an update. Arch Toxicol. 2015;89(6):899\u2013921.","journal-title":"Arch Toxicol"},{"issue":"17","key":"23101314_CR46","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/sj.onc.1209277","volume":"25","author":"MR Campbell","year":"2006","unstructured":"Campbell, MR, Wang, Y, Andrew, SE, Liu, Y MsH2 deficiency leads to chromosomal abnormalities, centrosome amplification, and telomere capping defect. Oncogene. 2006;25(17):2531\u20132536.","journal-title":"Oncogene"},{"issue":"7","key":"23101314_CR47","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1158\/0008-5472.CAN-04-3158","volume":"65","author":"MR Campbell","year":"2005","unstructured":"Campbell, MR, Nation, PN, Andrew, SE A lack of DNA mismatch repair on an athymic murine background predisposes to hemato-logic malignancy. Cancer Res. 2005;65(7):2626\u20132635.","journal-title":"Cancer Res"},{"issue":"3","key":"23101314_CR48","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/hmg\/ddg056","volume":"12","author":"VC Wheeler","year":"2003","unstructured":"Wheeler, VC, Lebel, LA, Vrbanac, V, Teed, A, te Riele, H, MacDonald, ME Mismatch repair gene MsH2 modifies the timing of early disease in Hdh(Q111) striatum. Hum Mol Genet. 2003;12(3):273\u2013281.","journal-title":"Hum Mol Genet"},{"issue":"16","key":"23101314_CR49","first-page":"6131","volume":"61","author":"G Lal","year":"2001","unstructured":"Lal, G, Ash, C, Hay, K, et al. Suppression of intestinal polyps in MsH2-deficient and non-MsH2-deficient multiple intestinal neo-plasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1\/2 inhibitor. Cancer Res. 2001;61(16): 6131\u20136136.","journal-title":"Cancer Res"},{"issue":"3","key":"23101314_CR50","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3390\/cancers6031597","volume":"6","author":"G Bridge","year":"2014","unstructured":"Bridge, G, Rashid, S, Martin, SA DNA mismatch repair and oxi-dative DNA damage: implications for cancer biology and treatment. Cancers. 2014;6(3):1597\u20131614.","journal-title":"Cancers"},{"issue":"10","key":"23101314_CR51","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1158\/0008-5472.CAN-08-3292","volume":"69","author":"M D Russo","year":"2009","unstructured":"Russo, MT, De Luca, G, Casorelli, I, et al. Role of MUTYH and MSH2 in the control of oxidative DNA damage, genetic instability, and tumorigenesis. Cancer Res. 2009;69(10): 4372\u20134379.","journal-title":"Cancer Res"},{"issue":"11","key":"23101314_CR52","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S1568-7864(02)00143-X","volume":"1","author":"LB Meira","year":"2002","unstructured":"Meira, LB, Cheo, DL, Reis, AM, et al. Mice defective in the mismatch repair gene MsH2 show increased predisposition to UVB radiation-induced skin cancer. DNA Repair. 2002;1(11): 929\u2013934.","journal-title":"DNA Repair"},{"issue":"1","key":"23101314_CR53","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ng0995-64","volume":"11","author":"AH Reitmair","year":"1995","unstructured":"Reitmair, AH, Schmits, R, Ewel, A, et al. MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet. 1995; 11(1):64\u201370.","journal-title":"Nat Genet"},{"issue":"5","key":"23101314_CR54","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3892\/ol.2014.2482","volume":"8","author":"KH Yoo","year":"2014","unstructured":"Yoo, KH, Won, KY, Lim, SJ, Park, YK, Chang, SG Deficiency of MSH2 expression is associated with clear cell renal cell carci-noma. Oncol Lett. 2014;8(5):2135\u20132139.","journal-title":"Oncol Lett"},{"key":"23101314_CR55","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1038\/ncomms5988","volume":"5","author":"CC Pritchard","year":"2014","unstructured":"Pritchard, CC, Morrissey, C, Kumar, A, et al. Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer. Nat Commun. 2014;5:4988.","journal-title":"Nat Commun"},{"issue":"6","key":"23101314_CR56","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1053\/j.gastro.2014.08.041","volume":"147","author":"S Haraldsdottir","year":"2014","unstructured":"Haraldsdottir, S, Hampel, H, Tomsic, J, et al. Colon and endome-trial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. Gastroenterology. 2014;147(6):1308\u20131316.e1301.","journal-title":"Gastroenterology"},{"issue":"3","key":"23101314_CR57","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1525-1438.2001.01013.x","volume":"11","author":"F Amant","year":"2001","unstructured":"Amant, F, Dorfling, CM, Dreyer, L, Vergote, I, Lindeque, BG, Van Rensburg, EJ Microsatellite instability in uterine sarcomas. Int J Gynecol Cancer. 2001;11(3):218\u2013223.","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"23101314_CR58","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/PGP.0b013e31829ff239","volume":"33","author":"LN Hoang","year":"2014","unstructured":"Hoang, LN, Ali, RH, Lau, S, Gilks, CB, Lee, CH Immunohisto-chemical survey of mismatch repair protein expression in uterine sarcomas and carcinosarcomas. Int J Gynecol Pathol. 2014;33(5): 483\u2013491.","journal-title":"Int J Gynecol Pathol"},{"issue":"6907","key":"23101314_CR59","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","volume":"419","author":"S Varambally","year":"2002","unstructured":"Varambally, S, Dhanasekaran, SM, Zhou, M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 2002;419(6907):624\u2013629.","journal-title":"Nature"},{"issue":"4","key":"23101314_CR60","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1046\/j.1365-2141.2001.02641.x","volume":"112","author":"HP Visser","year":"2001","unstructured":"Visser, HP, Gunster, MJ, Kluin-Nelemans, HC, et al. The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma. Br J Haematol. 2001;112(4): 950\u2013958.","journal-title":"Br J Haematol"},{"issue":"11","key":"23101314_CR61","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1158\/1940-6207.CAPR-11-0130","volume":"4","author":"W Cao","year":"2011","unstructured":"Cao, W, Younis, RH, Li, J, et al. EZH2 promotes malignant phe-notypes and is a predictor of oral cancer development in patients with oral leukoplakia. Cancer Prev Res (Phila). 2011;4(11): 1816\u20131824.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"9","key":"23101314_CR62","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1158\/1078-0432.CCR-10-2156","volume":"17","author":"A Chase","year":"2011","unstructured":"Chase, A, Cross, NC Aberrations of EZH2 in cancer. Clin Cancer Res. 2011;17(9):2613\u20132618.","journal-title":"Clin Cancer Res"},{"issue":"1-2","key":"23101314_CR63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mrfmmm.2008.07.010","volume":"647","author":"JA Simon","year":"2008","unstructured":"Simon, JA, Lange, CA Roles of the EZH2 histone methyl-transferase in cancer epigenetics. Mutat Res. 2008;647(1-2): 21\u201329.","journal-title":"Mutat Res"},{"issue":"11","key":"23101314_CR64","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/cdd.2011.48","volume":"18","author":"Z Wu","year":"2011","unstructured":"Wu, Z, Lee, ST, Qiao, Y, et al. Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage. Cell Death Differ. 2011;18(11):1771\u20131779.","journal-title":"Cell Death Differ"},{"issue":"3","key":"23101314_CR65","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.stem.2010.08.002","volume":"7","author":"M Sauvageau","year":"2010","unstructured":"Sauvageau, M, Sauvageau, G Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell. 2010;7(3):299\u2013313.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"23101314_CR66","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3892\/or.2013.2922","volume":"31","author":"S Nakagawa","year":"2014","unstructured":"Nakagawa, S, Sakamoto, Y, Okabe, H, et al. Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells. Oncol Rep. 2014;31(2):983\u2013988.","journal-title":"Oncol Rep"},{"issue":"2","key":"23101314_CR67","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.lungcan.2012.08.003","volume":"78","author":"J Kikuchi","year":"2012","unstructured":"Kikuchi, J, Takashina, T, Kinoshita, I, et al. Epigenetic therapy with 3-deazaneplanocin, A, an inhibitor of the histone methyltransfer-ase EZH2, inhibits growth of non-small cell lung cancer cells. Lung Cancer. 2012;78(2):138\u2013143.","journal-title":"Lung Cancer"},{"key":"23101314_CR68","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1476-4598-10-40","volume":"10","author":"F Crea","year":"2011","unstructured":"Crea, F, Hurt, EM, Mathews, LA, et al. Pharmacologic disruption of polycomb repressive complex 2 inhibits tumorigenicity and tumor progression in prostate cancer. Mol Cancer. 2011; 10:40.","journal-title":"Mol Cancer"},{"issue":"6","key":"23101314_CR69","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ng.159","volume":"40","author":"Y Kondo","year":"2008","unstructured":"Kondo, Y, Shen, L, Cheng, AS, et al. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet. 2008;40(6):741\u2013750.","journal-title":"Nat Genet"},{"issue":"5","key":"23101314_CR70","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1101\/gad.415507","volume":"21","author":"AP Bracken","year":"2007","unstructured":"Bracken, AP, Kleine-Kohlbrecher, D, Dietrich, N, et al. The poly-comb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev. 2007;21(5): 525\u2013530.","journal-title":"Genes Dev"},{"issue":"4","key":"23101314_CR71","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1158\/1541-7786.MCR-10-0511","volume":"9","author":"T Fan","year":"2011","unstructured":"Fan, T, Jiang, S, Chung, N, et al. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21\/CDKN1A expression. Mol Cancer Res. 2011; 9(4):418\u2013429.","journal-title":"Mol Cancer Res"},{"issue":"3","key":"23101314_CR72","doi-asserted-by":"crossref","first-page":"269","DOI":"10.7785\/tcrt.2012.500315","volume":"12","author":"J Zhong","year":"2013","unstructured":"Zhong, J, Min, L, Huang, H, et al. EZH2 regulates the expression of p16 in the nasopharyngeal cancer cells. Technol Cancer Res Treat. 2013;12(3):269\u2013274.","journal-title":"Technol Cancer Res Treat"},{"issue":"7","key":"23101314_CR73","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.humpath.2015.01.023","volume":"46","author":"L Lin","year":"2015","unstructured":"Lin, L, Zheng, Y, Tu, Y, et al. MicroRNA-144 suppresses tumor-igenesis and tumor progression of astrocytoma by targeting EZH2. Hum Pathol. 2015;46(7):971\u2013980.","journal-title":"Hum Pathol"},{"issue":"13","key":"23101314_CR74","doi-asserted-by":"crossref","first-page":"10868","DOI":"10.18632\/oncotarget.3451","volume":"6","author":"DL Chen","year":"2015","unstructured":"Chen, DL, Zhang, DS, Lu, YX, et al. microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer. Oncotarget. 2015;6(13): 10868\u201310879.","journal-title":"Oncotarget"},{"issue":"5","key":"23101314_CR75","first-page":"4972","volume":"8","author":"F Liu","year":"2015","unstructured":"Liu, F, He, Y, Shu, R, Wang, S MicroRNA-1297 regulates hepato-cellular carcinoma cell proliferation and apoptosis by targeting EZH2. Int J Clin Exp Pathol. 2015;8(5):4972\u20134980.","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"23101314_CR76","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11060-015-1753-x","volume":"122","author":"J Sun","year":"2015","unstructured":"Sun, J, Zheng, G, Gu, Z, Guo, Z MiR-137 inhibits proliferation and angiogenesis of human glioblastoma cells by targeting EZH2. J Neurooncol. 2015;122(3):481\u2013489.","journal-title":"J Neurooncol"},{"issue":"4","key":"23101314_CR77","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ajog.2005.02.097","volume":"193","author":"RA Canevari","year":"2005","unstructured":"Canevari, RA, Pontes, A, Rosa, FE, Rainho, CA, Rogatto, SR Independent clonal origin of multiple uterine leiomyomas that was determined by X chromosome inactivation and microsatellite analysis. Am J Obstet Gynecol. 2005;193(4): 1395\u20131403.","journal-title":"Am J Obstet Gynecol"},{"issue":"1A","key":"23101314_CR78","first-page":"349","volume":"18","author":"D French","year":"1998","unstructured":"French, D, Cermele, C, Lombardi, AM, et al. Microsatellite altera-tions in uterine leiomyomas. Anticancer Res. 1998;18(1A): 349\u2013351.","journal-title":"Anticancer Res"},{"issue":"2","key":"23101314_CR79","first-page":"401","volume":"19","author":"M Li","year":"2008","unstructured":"Li, M, Liu, L, Wang, Z, et al. Overexpression of hMSH2 and hMLH1 protein in certain gastric cancers and their surrounding mucosae. Oncol Rep. 2008;19(2):401\u2013406.","journal-title":"Oncol Rep"},{"issue":"5","key":"23101314_CR80","doi-asserted-by":"crossref","first-page":"373","DOI":"10.5152\/tjg.2015.0139","volume":"26","author":"A Dracea","year":"2015","unstructured":"Dracea, A, Angelescu, C, Danciulescu, M, Ciurea, M, Ioana, M, Burada, F Mismatch repair gene expression in gastroesophageal cancers. Turk J Gastroenterol. 2015;26(5):373\u2013377.","journal-title":"Turk J Gastroenterol"},{"issue":"1","key":"23101314_CR81","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molcel.2014.04.028","volume":"55","author":"M Zhang","year":"2014","unstructured":"Zhang, M, Xiang, S, Joo, HY, et al. HDAC6 deacetylates and ubi-quitinates MSH2 to maintain proper levels of MutSa. Molecular Cell. 2014;55(1):31\u201346.","journal-title":"Molecular Cell"},{"issue":"9","key":"23101314_CR82","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1101\/gad.1524107","volume":"21","author":"J Tan","year":"2007","unstructured":"Tan, J, Yang, X, Zhuang, L, et al. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selec-tively induces apoptosis in cancer cells. Genes Dev. 2007;21(9): 1050\u20131063.","journal-title":"Genes Dev"},{"issue":"2","key":"23101314_CR83","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.gde.2009.03.001","volume":"19","author":"J Muller","year":"2009","unstructured":"Muller, J, Verrijzer, P Biochemical mechanisms of gene regulation by polycomb group protein complexes. Curr Opin Genet Dev. 2009;19(2):150\u2013158.","journal-title":"Curr Opin Genet Dev"},{"issue":"2","key":"23101314_CR84","first-page":"175","volume":"7","author":"P Volkel","year":"2015","unstructured":"Volkel, P, Dupret, B, Le Bourhis, X, Angrand, PO Diverse involvement of EZH2 in cancer epigenetics. Am J Transl Res. 2015;7(2): 175\u2013193.","journal-title":"Am J Transl Res"},{"issue":"14","key":"23101314_CR85","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1128\/MCB.00162-07","volume":"27","author":"B Shi","year":"2007","unstructured":"Shi, B, Liang, J, Yang, X, et al. Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol Cell Biol. 2007;27(14):5105\u20135119.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"23101314_CR86","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.molcel.2011.08.011","volume":"43","author":"ST Lee","year":"2011","unstructured":"Lee, ST, Li, Z, Wu, Z, et al. Context-specific regulation of NF-kappaB target gene expression by EZH2 in breast cancers. Molecular Cell. 2011;43(5):798\u2013810.","journal-title":"Molecular Cell"},{"issue":"10","key":"23101314_CR87","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/1541-7786.MCR-14-0034","volume":"12","author":"SB Gao","year":"2014","unstructured":"Gao, SB, Zheng, QF, Xu, B, et al. EZH2 represses target genes through H3K27-dependent and H3K27-independent mechanisms in hepatocellular carcinoma. Mol Cancer Res. 2014;12(10): 1388\u20131397.","journal-title":"Mol Cancer Res"},{"issue":"5-7","key":"23101314_CR88","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10735-006-9042-9","volume":"37","author":"M Zeidler","year":"2006","unstructured":"Zeidler, M, Kleer, CG The Polycomb group protein Enhancer of Zeste 2: its links to DNA repair and breast cancer. J Mol Histol. 2006;37(5-7):219\u2013223.","journal-title":"J Mol Histol"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719116638186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719116638186","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719116638186\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719116638186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719116638186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T01:50:55Z","timestamp":1656813055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719116638186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":88,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["23101314"],"URL":"https:\/\/doi.org\/10.1177\/1933719116638186","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"1 October 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}